Dr Stephen Falk

Stephen qualified from Liverpool University in 1983 and spent a period in Liverpool undertaking a general medical rotation. He then trained in oncology in Cardiff and Cambridge becoming a Consultant in Bristol in 1994. He also has sessional commitments at Southmead Hospital, Bristol and attends the Taunton Nuffield Hospital. His major clinical interest is gastro-intestinal cancer (oesophagus, stomach, pancreas and colo-rectal). A further interest in lung cancer and clinical research was stimulated as a MRC Clincial Scientist in Norman Bleehens' unit in Cambridge where the MRC Cancer Trials Unit was situated at the time. A MD related to lung cancer and scheduling of topoisomerase poisons with and without radiation is the basis of on-going interest in chemo-radiation interactions. Stephen has a major interest in research and where possible all patients who are referred will be offered an appropriate clinical trial. Until recently he had a challenging clinical load seeing up to 1,000 new patients with cancer annually. More recently until 2018 he has been Clinical Director of the West of England Clinical Research Network whose job is to fund the NHS costs of delivering research activity in the NHS and is also a member of the NCRI Upper GI Studies Group, and chaired the Pancreatic Sub Group until 2018.

Upper gastrointestinal tract, hepato-biliary and colorectal cancer, lung cancer, lymphomas and skin cancers, radiotherapy and chemotherapy.